SCHEMBL19543713

SCHEMBL19543713

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4cccc(-c5ccncc5)c4)cc(-c4cc5ccccc5c5ccccc45)c3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.50
KDM4E B2RXH2 7/20 0.42
MAPT P10636 7/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
LMNA P02545 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 2/20 0.42
NOTUM Q6P988 1/20 0.42
PIK3CA P42336 1/20 0.40
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
POLB P06746 2/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
TGFBR1 P36897 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17932324 0.97 CYP11B1 (0.53) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL31463161 0.96 CYP11B1 (0.51) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL31463138 0.96 CYP11B1 (0.51) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL19486711 0.96 CYP11B1 (0.51) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL24255975 0.93 CYP11B1 (0.49) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL24492885 0.91 CYP11B1 (0.58) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL22512511 0.90 CYP11B1 (0.49) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL17932319 0.90 CYP11B1 (0.51) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL31369124 0.90 CYP11B1 (0.51) CYP11B1KDM4EMAPTALDH1A1HPGD
SCHEMBL23065684 0.88 CYP11B1 (0.50) CYP11B1KDM4EMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 CYP11B1 759/4885KDM4E 2540/4885MAPT 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.